{"id":"https://openalex.org/W2783173849","doi":"https://doi.org/10.1080/19420862.2018.1424610","title":"Development and characterization of an anti-rituximab monoclonal antibody panel","display_name":"Development and characterization of an anti-rituximab monoclonal antibody panel","alternate_titles":[],"publication_year":2018,"publication_date":"2018-01-08","ids":{"openalex":"https://openalex.org/W2783173849","doi":"https://doi.org/10.1080/19420862.2018.1424610","mag":"2783173849","pmid":"https://pubmed.ncbi.nlm.nih.gov/29309213","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5916554"},"language":"en","primary_location":{"id":"doi:10.1080/19420862.2018.1424610","doi":"https://doi.org/10.1080/19420862.2018.1424610","is_oa":true,"landing_page_url":"https://doi.org/10.1080/19420862.2018.1424610","pdf_url":null,"source":{"id":"https://openalex.org/S169123381","display_name":"mAbs","issn_l":"1942-0862","issn":["1942-0862","1942-0870"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315740","host_organization_name":"Landes Bioscience","host_organization_lineage":["https://openalex.org/P4310315740"],"host_organization_lineage_names":["Landes Bioscience"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"mAbs","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2783173849"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1080/19420862.2018.1424610","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068615391","display_name":"Minoru Tada","orcid":"https://orcid.org/0000-0003-4739-1259","observed_orcids":["https://orcid.org/0000-0003-4739-1259"]},"institutions":[{"id":"https://openalex.org/I4210151964","display_name":"National Institute of Health Sciences","ror":"https://ror.org/04s629c33","country_code":"JP","type":"facility","lineage":["https://openalex.org/I1333985979","https://openalex.org/I4210151964"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Minoru Tada","raw_affiliation_strings":["Division of Biological Chemistry and Biologicals, National Institute of Health Sciences, Kawasaki, Kanagawa, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Biological Chemistry and Biologicals, National Institute of Health Sciences, Kawasaki, Kanagawa, Japan","institution_ids":["https://openalex.org/I4210151964"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108772444","display_name":"Takuo Suzuki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151964","display_name":"National Institute of Health Sciences","ror":"https://ror.org/04s629c33","country_code":"JP","type":"facility","lineage":["https://openalex.org/I1333985979","https://openalex.org/I4210151964"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takuo Suzuki","raw_affiliation_strings":["Division of Biological Chemistry and Biologicals, National Institute of Health Sciences, Kawasaki, Kanagawa, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Biological Chemistry and Biologicals, National Institute of Health Sciences, Kawasaki, Kanagawa, Japan","institution_ids":["https://openalex.org/I4210151964"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5051239108","display_name":"Akiko Ishii\u2010Watabe","orcid":"https://orcid.org/0000-0003-2167-2263","observed_orcids":["https://orcid.org/0000-0003-2167-2263"]},"institutions":[{"id":"https://openalex.org/I4210151964","display_name":"National Institute of Health Sciences","ror":"https://ror.org/04s629c33","country_code":"JP","type":"facility","lineage":["https://openalex.org/I1333985979","https://openalex.org/I4210151964"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Akiko Ishii-Watabe","raw_affiliation_strings":["Division of Biological Chemistry and Biologicals, National Institute of Health Sciences, Kawasaki, Kanagawa, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Biological Chemistry and Biologicals, National Institute of Health Sciences, Kawasaki, Kanagawa, Japan","institution_ids":["https://openalex.org/I4210151964"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5068615391"],"corresponding_institution_ids":["https://openalex.org/I4210151964"],"apc_list":{"value":2915,"currency":"GBP","value_usd":3575},"apc_paid":{"value":2915,"currency":"GBP","value_usd":3575},"fwci":1.9275,"has_fulltext":true,"cited_by_count":89,"citation_normalized_percentile":{"value":0.85080565,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"10","issue":"3","first_page":"370","last_page":"379"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.7289999723434448,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.7289999723434448,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.26249998807907104,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anti-drug-antibodies","display_name":"anti-drug antibodies","score":0.925000011920929},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.8809999823570251},{"id":"https://openalex.org/keywords/immunogenicity-assessment","display_name":"immunogenicity assessment","score":0.8560000061988831},{"id":"https://openalex.org/keywords/reference-materials","display_name":"reference materials","score":0.531000018119812},{"id":"https://openalex.org/keywords/chimeric-monoclonal-antibody","display_name":"chimeric monoclonal antibody","score":0.7739999890327454},{"id":"https://openalex.org/keywords/neutralization-potency","display_name":"neutralization potency","score":0.8149999976158142},{"id":"https://openalex.org/keywords/complement-dependent-cytotoxicity","display_name":"complement-dependent cytotoxicity","score":0.9390000104904175},{"id":"https://openalex.org/keywords/antibody-dependent-cellular-cytotoxicity","display_name":"antibody-dependent cellular cytotoxicity","score":0.9940000176429749},{"id":"https://openalex.org/keywords/epitope-specificity","display_name":"epitope specificity","score":0.621999979019165}],"concepts":[{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.8832250833511353},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.8587226867675781},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.7966529726982117},{"id":"https://openalex.org/C195616568","wikidata":"https://www.wikidata.org/wiki/Q128711","display_name":"Epitope","level":3,"score":0.5754994750022888},{"id":"https://openalex.org/C18031839","wikidata":"https://www.wikidata.org/wiki/Q5009796","display_name":"CD20","level":3,"score":0.5568978190422058},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5130611658096313},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.40811091661453247},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.3816635310649872},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.37933170795440674},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.24143630266189575}],"mesh":[{"descriptor_ui":"D000069283","descriptor_name":"Rituximab","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1080/19420862.2018.1424610","doi":"https://doi.org/10.1080/19420862.2018.1424610","is_oa":true,"landing_page_url":"https://doi.org/10.1080/19420862.2018.1424610","pdf_url":null,"source":{"id":"https://openalex.org/S169123381","display_name":"mAbs","issn_l":"1942-0862","issn":["1942-0862","1942-0870"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315740","host_organization_name":"Landes Bioscience","host_organization_lineage":["https://openalex.org/P4310315740"],"host_organization_lineage_names":["Landes Bioscience"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"mAbs","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:5916554","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5916554/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5916554/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"MAbs","raw_type":"Text"},{"id":"pmh:oai:europepmc.org:4842109","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5916554","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:29309213","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29309213","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"mAbs","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1080/19420862.2018.1424610","doi":"https://doi.org/10.1080/19420862.2018.1424610","is_oa":true,"landing_page_url":"https://doi.org/10.1080/19420862.2018.1424610","pdf_url":null,"source":{"id":"https://openalex.org/S169123381","display_name":"mAbs","issn_l":"1942-0862","issn":["1942-0862","1942-0870"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315740","host_organization_name":"Landes Bioscience","host_organization_lineage":["https://openalex.org/P4310315740"],"host_organization_lineage_names":["Landes Bioscience"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"mAbs","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320311405","display_name":"Japan Agency for Medical Research and Development","ror":"https://ror.org/004rtk039"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2783173849.pdf","grobid_xml":"https://content.openalex.org/works/W2783173849.grobid-xml"},"referenced_works_count":38,"referenced_works":["https://openalex.org/W1517634074","https://openalex.org/W1588988525","https://openalex.org/W1971242419","https://openalex.org/W1976548137","https://openalex.org/W1976821928","https://openalex.org/W1980003919","https://openalex.org/W1997999969","https://openalex.org/W2013754528","https://openalex.org/W2028450449","https://openalex.org/W2035118667","https://openalex.org/W2039618516","https://openalex.org/W2043228552","https://openalex.org/W2049550615","https://openalex.org/W2055886080","https://openalex.org/W2075632612","https://openalex.org/W2075901113","https://openalex.org/W2089887839","https://openalex.org/W2093921560","https://openalex.org/W2101168807","https://openalex.org/W2102251969","https://openalex.org/W2106621962","https://openalex.org/W2112335360","https://openalex.org/W2115281403","https://openalex.org/W2123556713","https://openalex.org/W2140167069","https://openalex.org/W2147810684","https://openalex.org/W2148043455","https://openalex.org/W2152353173","https://openalex.org/W2196578399","https://openalex.org/W2290515360","https://openalex.org/W2346991568","https://openalex.org/W2491446109","https://openalex.org/W2507392905","https://openalex.org/W2587532658","https://openalex.org/W2605134986","https://openalex.org/W2608850138","https://openalex.org/W2753400018","https://openalex.org/W2756545627"],"related_works":["https://openalex.org/W2997329586","https://openalex.org/W7213266021","https://openalex.org/W3062976875","https://openalex.org/W3087611698","https://openalex.org/W1988054374","https://openalex.org/W2756545627","https://openalex.org/W2774235371","https://openalex.org/W4411589711","https://openalex.org/W4400644316","https://openalex.org/W2791731545"],"abstract_inverted_index":{"During":[0],"the":[1,14,49,63,71,96,138,145,150,166,170,186,205,212,231],"development":[2,233],"of":[3,16,35,51,89,99,102,137,142,159,190,223,236],"monoclonal":[4],"antibodies":[5,18],"(mAbs)":[6],"and":[7,24,40,61,119,121,130,144,152,188,202,234],"other":[8,77],"therapeutic":[9],"proteins,":[10],"immunogenicity,":[11],"in":[12],"particular":[13],"induction":[15],"anti-drug":[17],"(ADAs),":[19],"is":[20,28,43,66],"an":[21],"important":[22],"concern,":[23],"thus":[25],"immunogenicity":[26,46,239],"assessment":[27],"a":[29,87],"requirement":[30],"for":[31,38,45,125,169,177,230,238],"their":[32,157],"approval.":[33],"Establishment":[34],"appropriate":[36],"methods":[37,78],"detecting":[39],"characterizing":[41],"ADAs":[42,90,167,213,224],"necessary":[44],"assessment,":[47],"but":[48],"lack":[50],"commonly":[52],"available":[53],"reference":[54,82],"standards":[55],"makes":[56],"it":[57],"difficult":[58,68],"to":[59,69,184,197,210],"compare":[60,70,198],"evaluate":[62],"methods.":[64],"It":[65],"also":[67],"data":[72],"with":[73,156,214],"those":[74],"obtained":[75],"by":[76],"or":[79],"facilities":[80],"without":[81],"standards.":[83],"Here,":[84],"we":[85,193],"developed":[86,172],"panel":[88,97,173,196,222],"against":[91,225],"anti-CD20":[92],"rituximab":[93,143,226],"(Rituxan\u00ae,":[94],"MabThera\u00ae);":[95],"consisted":[98],"eight":[100],"clones":[101],"recombinant":[103],"human-rat":[104],"chimeric":[105],"mAbs":[106,112],"that":[107,165,204,220],"target":[108],"rituximab.":[109,191],"The":[110,134],"anti-rituximab":[111,146],"showed":[113],"different":[114,122,182,208,215],"binding":[115,216],"properties":[116],"(specificity,":[117],"epitope":[118],"affinity),":[120],"neutralization":[123],"potencies":[124],"CD20":[126],"binding,":[127],"complement-dependent":[128],"cytotoxicity":[129],"antibody-dependent":[131],"cell-mediated":[132],"cytotoxicity.":[133],"molecular":[135],"size":[136],"immune":[139],"complex":[140],"consisting":[141],"mAb":[147],"differed":[148],"among":[149],"clones,":[151],"was":[153],"well":[154],"correlated":[155],"level":[158],"Fc\u03b3-receptor":[160],"activation.":[161],"These":[162],"results":[163],"suggest":[164],"chosen":[168],"newly":[171],"are":[174],"suitable":[175],"surrogates":[176],"human":[178],"ADAs,":[179],"which":[180],"exhibit":[181],"potential":[183],"affect":[185],"efficacy":[187],"safety":[189],"Next,":[192],"used":[194],"this":[195],"several":[199],"ADA-detecting":[200],"assays":[201,206,237],"revealed":[203],"had":[207],"abilities":[209],"detect":[211],"characteristics.":[217],"We":[218],"conclude":[219],"our":[221],"will":[227],"be":[228],"useful":[229],"future":[232],"characterization":[235],"assessment.":[240]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2783173849","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":59},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2018-01-26T00:00:00"}
